Cellular therapies for sickle cell disease: Should we be calling them a cure?

Authors

Institutions

Publication Details

Journal
HemaSphere
Published
2025-12-01
DOI
https://doi.org/10.1002/hem3.70283
Primary Topic
Hemoglobinopathies and Related Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cellular therapies for sickle cell disease: Should we be calling them a cure?

Zainab Garba-Sani, Lydia Okoibhole, Stephen P. Hibbs, Funmi Dasaolu
HemaSphere
Hemoglobinopathies and Related Disorders
article

Cellular therapies for sickle cell disease: Should we be calling them a cure?

Zainab Garba-Sani, Lydia Okoibhole, Stephen P. Hibbs, Funmi Dasaolu
article en

Abstract

No abstract available for this paper.
HemaSphereVol. 9(12)
Queen Mary University of London (GB), King's College London (GB), University of Cambridge (GB), Florence Nightingale Foundation (GB), Multiple Sclerosis Society (GB), Wellcome Sanger Institute (GB), Stanford Medicine (US), Wellcome Connecting Science (GB), Oxford University Hospitals NHS Trust (GB)
Openalex Percentile: Top 40%
Hemoglobinopathies and Related Disorders
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.